Valuation: Bioneer Corporation

Market Cap 17TCr 13Cr 11Cr 10Cr 9.43Cr 18Cr 1.2TCr 18Cr 124.45Cr 50Cr 636.06Cr 48Cr 47Cr 2.01TCr P/E 2024
-23.6x
P/E 2025 -117x
Enterprise Value 19TCr 14Cr 12Cr 11Cr 10Cr 19Cr 1.3TCr 20Cr 134.51Cr 54Cr 687.49Cr 52Cr 50Cr 2.17TCr EV / Sales 2024
1.59x
EV / Sales 2025 1.04x
Free-Float
82.04%
Yield 2024 *
-
Yield 2025 -
1 day-0.45%
1 week-4.58%
Current month-2.20%
1 month-22.29%
3 months-4.03%
6 months-34.90%
Current year-47.76%
1 week 6,360
Extreme 6360
6,960
1 month 6,360
Extreme 6360
9,050
Current year 5,470
Extreme 5470
14,210
1 year 5,470
Extreme 5470
15,500
3 years 5,470
Extreme 5470
39,100
5 years 5,470
Extreme 5470
77,600
10 years 4,355
Extreme 4355
98,800
Manager TitleAgeSince
Chief Executive Officer 64 01/08/1992
Corporate Officer/Principal 62 28/03/2024
Corporate Officer/Principal 51 31/03/2025
Director TitleAgeSince
Director/Board Member 64 18/02/2011
Director/Board Member 62 01/05/1997
Director/Board Member 64 01/02/2000
Date Insider Type Main position Quantity % Market Cap. Importance
12/06/25 Exercice

Director

2,625 0.0102%
03/03/25 Buy

Chief Executive Officer

3,000 0.0116%
22/01/25 Buy 1,579 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%-4.58%-55.03%-78.76% 13Cr
+3.80%+8.10%+63.78%+77.70% 6.94TCr
-1.86%-0.84%+8.54%+73.32% 5.72TCr
-2.54%+1.71%+23.25%+97.71% 5.76TCr
+0.41%-3.70%+26.06%+34.32% 4.37TCr
+2.51%+4.22%+20.49%+110.71% 4.4TCr
-11.04%-6.63%+199.38%+701.67% 3.81TCr
+7.50%+13.58%+29.07%+64.46% 3.63TCr
-3.38%-10.33%+87.84%+75.22% 3.26TCr
-2.18%+7.06%+36.06%-4.95% 2.55TCr
Average -0.56%+2.30%+43.94%+115.14% 4.05TCr
Weighted average by Cap. -0.26%+3.11%+51.21%+130.93%

Financials

2024 2025
Net sales 29TCr 22Cr 19Cr 18Cr 16Cr 30Cr 2.05TCr 31Cr 212.83Cr 85Cr 1.09TCr 82Cr 80Cr 3.43TCr 33TCr 24Cr 22Cr 20Cr 18Cr 34Cr 2.31TCr 35Cr 238.99Cr 96Cr 1.22TCr 92Cr 90Cr 3.85TCr
Net income -2.06TCr -1.52Cr -1.36Cr -1.24Cr -1.13Cr -2.13Cr -143.82Cr -2.19Cr -15Cr -5.96Cr -76Cr -5.71Cr -5.59Cr -240.35Cr -281.32Cr -20.8L -18.53L -16.95L -15.44L -29.1L -20Cr -29.89L -2.04Cr -81.44L -10Cr -78.07L -76.39L -33Cr
Net Debt -2.05TCr -1.52Cr -1.35Cr -1.24Cr -1.13Cr -2.12Cr -143.5Cr -2.18Cr -15Cr -5.95Cr -76Cr -5.7Cr -5.58Cr -239.81Cr 1.39TCr 1.03Cr 91.57L 83.75L 76.28L 1.44Cr 97Cr 1.48Cr 10Cr 4.02Cr 51Cr 3.86Cr 3.77Cr 162.28Cr
Projected Income Statement - Annual - Bioneer Corporation
Logo Bioneer Corporation
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and ribonucleic acid interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Company’s products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The Company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.
Employees
383
Date Price Change Volume
05/26/05 ₩6,660.00 -0.45% 1,27,222
04/26/04 ₩6,690.00 +1.83% 1,45,126
03/26/03 ₩6,570.00 -4.23% 93,509
02/26/02 ₩6,860.00 +0.73% 76,977
30/26/30 ₩6,810.00 -2.44% 1,35,840
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Bioneer Corporation
  1. Stock Market
  2. Stocks
  3. A064550 Stock